Author | Owen O'Connor, MD, PhD | OncLive

Author | Owen O'Connor, MD, PhD

Articles

Dr. O'Connor on Treatment Options Following Ibrutinib Progression in MCL

January 25, 2018

Video

Owen O'Connor, MD, PhD, professor of medicine and experimental therapeutics, director of the Center for Lymphoid Malignancies, Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, discusses treatment options following progression on ibrutinib (Imbruvica) for patients with mantle cell lymphoma (MCL).

Dr. O'Connor on Acalabrutinib Versus Ibrutinib in MCL

January 03, 2018

Video

Owen O'Connor, MD, PhD, Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, discusses acalabrutinib (Calquence) versus ibrutinib (Imbruvica) for the treatment of patients with mantle cell lymphoma

Dr. O'Connor Discusses Acalabrutinib in MCL

December 06, 2017

Video

Owen O'Connor, MD, PhD, discusses acalabrutinib (Calquence) in mantle cell lymphoma (MCL).

Dr. O'Connor on the Role of Obinutuzumab in Follicular Lymphoma

November 28, 2017

Video

Owen O'Connor, MD, PhD, professor of medicine and Experimental Therapeutics, director of the Center for Lymphoid Malignancies, Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, discusses the role of obinutuzumab (Gazyva) in the treatment of patients with follicular lymphoma.

x